BBY vs EBS · P/E 14, rev $41.53B vs rev $1.04B
Best Buy Co. Inc (BBY) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BBY revenue for 2025-02-01 was $41.53B. Net income was $927.0M. Revenue was down 4.4% from 2024-02-03 to 2025-02-01. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BBY and EBS stock pages for the full models.
Not investment advice.